Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.
暂无分享,去创建一个
J. Gensel | P. Nelson | Haining Zhu | J. Abisambra | J. Chen | Shelby Meier | Danielle N. Lyons | Michelle C. Bell | D. Lyons | Alexandria Ingram
[1] Janna H. Neltner,et al. Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.
[2] B. Lynn,et al. FUsed in sarcoma is a novel regulator of manganese superoxide dismutase gene transcription. , 2014, Antioxidants & redox signaling.
[3] R. Henning,et al. Increased protein aggregation in Zucker Diabetic Fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide , 2014, BMC Cell Biology.
[4] J. Rogers,et al. Allosteric Heat Shock Protein 70 Inhibitors Rapidly Rescue Synaptic Plasticity Deficits by Reducing Aberrant Tau , 2013, Biological Psychiatry.
[5] J. Abisambra,et al. Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation , 2013, Alzheimer's & Dementia.
[6] G. Davis,et al. EB1, p150Glued, and Clasp1 control endothelial tubulogenesis through microtubule assembly, acetylation, and apical polarization. , 2013, Blood.
[7] V. Uversky,et al. Imbalance of Hsp70 family variants fosters tau accumulation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] A. Wimo,et al. The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.
[9] U. Sengupta,et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau , 2012, Scientific Reports.
[10] M. Cockman,et al. DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau. , 2012, Journal of molecular biology.
[11] M. Feany,et al. Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo , 2012, Neuron.
[12] E. Mandelkow,et al. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. , 2012, Cold Spring Harbor perspectives in medicine.
[13] J. Gestwicki,et al. Cdc37/Hsp90 Protein Complex Disruption Triggers an Autophagic Clearance Cascade for TDP-43 Protein , 2012, The Journal of Biological Chemistry.
[14] D. Dinsdale,et al. Sustained translational repression by eIF2α-P mediates prion neurodegeneration , 2012, Nature.
[15] C. Brosnan,et al. Mice Devoid of Tau Have Increased Susceptibility to Neuronal Damage in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis , 2012, Journal of neuropathology and experimental neurology.
[16] T. Suhara,et al. Mechanistic involvement of the calpain‐calpastatin system in Alzheimer neuropathology , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] M. Kamasak,et al. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis , 2012, Multiple sclerosis.
[18] E. Mandelkow,et al. Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration , 2011, The EMBO journal.
[19] J. Koren,et al. Exploiting the Diversity of the Heat-Shock Protein Family for Primary and Secondary Tauopathy Therapeutics , 2011, Current neuropharmacology.
[20] U. Sengupta,et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice , 2011, Molecular Neurodegeneration.
[21] G. Drewes,et al. The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner , 2011, The Journal of cell biology.
[22] John Koren,et al. The diarylheptanoid (+)-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau. , 2011, Journal of natural products.
[23] J. Rogers,et al. Phosphorylation Dynamics Regulate Hsp27-Mediated Rescue of Neuronal Plasticity Deficits in Tau Transgenic Mice , 2010, The Journal of Neuroscience.
[24] J. Buchner,et al. The Hsp90 Cochaperone, FKBP51, Increases Tau Stability and Polymerizes Microtubules , 2010, The Journal of Neuroscience.
[25] J. Padmanabhan,et al. LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease , 2010, PloS one.
[26] N. Gusev,et al. Phosphorylation of more than one site is required for tight interaction of human tau protein with 14‐3‐3ζ , 2009, FEBS letters.
[27] G. Drewes,et al. Interactions of MAP/microtubule affinity regulating kinases with the adaptor complex AP-2 of clathrin-coated vesicles. , 2009, Cell motility and the cytoskeleton.
[28] Lisa J. Merlo,et al. Methamphetamine- and Trauma-Induced Brain Injuries: Comparative Cellular and Molecular Neurobiological Substrates , 2009, Biological Psychiatry.
[29] Haining Zhu,et al. Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord , 2009, The FEBS journal.
[30] G. Ness,et al. Activation of the hepatic LDL receptor promoter by thyroid hormone. , 2007, Biochimica et biophysica acta.
[31] I. Linhartova,et al. Ferritin associates with marginal band microtubules. , 2007, Experimental cell research.
[32] Cam Patterson,et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.
[33] Tudor A. Fulga,et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo , 2007, Nature Cell Biology.
[34] F. Cordelières,et al. A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.
[35] W. Markesbery,et al. Ribosome Dysfunction Is an Early Event in Alzheimer's Disease , 2005, The Journal of Neuroscience.
[36] Y. Han,et al. 14-3-3 Protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1. , 2004, Molecules and cells.
[37] R. Hayes,et al. A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. , 2004, Journal of neurotrauma.
[38] D. Bennett,et al. Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease , 2004, The Journal of Neuroscience.
[39] C. Cotman,et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. , 2004, The Journal of clinical investigation.
[40] R. Berry,et al. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Cotman,et al. Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain , 2002, Neurobiology of Disease.
[42] H. Paudel,et al. 14-3-3ζ Is an Effector of Tau Protein Phosphorylation* , 2000, The Journal of Biological Chemistry.
[43] E. Mandelkow,et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Hellen,et al. The joining of ribosomal subunits in eukaryotes requires eIF5B , 2000, Nature.
[45] G. Jicha,et al. A Conformation‐ and Phosphorylation‐Dependent Antibody Recognizing the Paired Helical Filaments of Alzheimer's Disease , 1997, Journal of neurochemistry.
[46] P. Janmey,et al. The structure of divalent cation-induced aggregates of PIP2 and their alteration by gelsolin and tau. , 1997, Biophysical journal.
[47] R. Hoffmann,et al. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. , 1997, Biochemistry.
[48] M. Hasegawa,et al. Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. , 1996, Dementia.
[49] P. Camilli,et al. A presynaptic inositol-5-phosphatase , 1996, Nature.
[50] M. Goedert,et al. Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase , 1995 .
[51] C. Saper,et al. Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep , 1995, Neurobiology of Aging.
[52] M. Billingsley,et al. Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase. , 1995, Molecular pharmacology.
[53] M. Pericak-Vance,et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[54] H. Braak,et al. Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.
[55] J. Walker,et al. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[56] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[57] L. Pradel,et al. Interaction between microtubule-associated protein tau and spectrin. , 1984, Biochimie.
[58] T D Pollard,et al. The interaction of actin filaments with microtubules and microtubule-associated proteins. , 1982, The Journal of biological chemistry.
[59] M. Kirschner,et al. A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[60] Philip Siekevitz,et al. Liver microsomes; an integrated morphological and biochemical study. , 1956 .
[61] S. Scheff,et al. Brain injury in the context of tauopathies. , 2014, Journal of Alzheimer's disease : JAD.
[62] Bradley T. Hyman,et al. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease , 2014, Acta Neuropathologica.
[63] A. Takashima. Tauopathies and tau oligomers. , 2013, Journal of Alzheimer's disease : JAD.
[64] G. Lederkremer,et al. Protein quality control, retention, and degradation at the endoplasmic reticulum. , 2011, International review of cell and molecular biology.
[65] M. Murphy,et al. Alzheimer's disease and the amyloid-beta peptide. , 2010, Journal of Alzheimer's disease : JAD.
[66] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[67] I. Duncan,et al. Selective myelin defects in the anterior medullary velum of the taiep mutant rat , 2001, Glia.
[68] Y. Ben-Ari,et al. Transient increase of tenascin-C in immature hippocampus: astroglial and neuronal expression , 1996, Journal of neurocytology.
[69] Papasozomenos Sc. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. , 1989 .
[70] L. Binder,et al. Phosphorylation determines two distinct species of Tau in the central nervous system. , 1987, Cell motility and the cytoskeleton.
[71] D. Eichler,et al. Characteristics of rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase. , 1986, The Biochemical journal.